Regulation of ADP-ribosyltransferase activity by ART domain dimerization in PARP15.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41162413.
- Also identified by DOI 10.1038/s41467-025-65315-9 and PMC identifier 12572374.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
PARP15 is a mono-ADP-ribosyltransferase that targets an unknown set of proteins as well as RNA. Its evolutionary relationship with PARP14 suggests roles in antiviral defence; its localization to stress granules points to functions in the regulation of translation. Here we show that the transferase domain of PARP15 dimerizes in solution; the formation of dimers is a prerequisite for catalytic activity and monomeric mutant variants of the domain are inactive. In cells, dimer-disrupting mutations abrogate catalytic activity and alter the subcellular localization of the full-length protein. Using biophysical methods, including X-ray crystallography and HDX-MS, we provide evidence for a regulatory mechanism by which dimerization enables correct target engagement rather than NAD<sup>+</sup> co-substrate binding, and by which the two protomers of the dimer operate independently of one another. Together, our results uncover a regulatory mechanism in a PARP family enzyme.
Medical subject headings
- Protein Multimerization
- ADP Ribose Transferases
- Poly(ADP-ribose) Polymerases